Grant Directory

Verified government funding opportunities

Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support

Open

National Institutes of Health

Deadline: federal

Updated: Oct 30, 2025

Summary

The National Institute on Drug Abuse (NIDA) aims to establish a Center to educate and support researchers in the formal development of new pharmacotherapeutics for substance use disorders (SUD), providing technical and financial support for initial experiments. Eligible applicants include state and local governments, educational institutions, nonprofits, small businesses, and other organizations, including tribal governments and foreign entities. Applications are not currently being solicited, but interested investigators are encouraged to prepare collaborations and responsive proposals for future consideration.

Full Description

Description

The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support. Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments.

Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].

Eligibility

Eligible applicants

Government

  • State governments
  • County governments
  • City or township governments
  • Federally recognized Native American tribal governments
  • Special district governments
  • Public and Indian housing authorities

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)

Business

  • Small businesses
  • For-profit organizations other than small businesses

Miscellaneous

  • Other

Additional information

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Grantor contact information

Description

--

Email

Tam.Nguyen@nih.gov

Tam.Nguyen@nih.gov

Apply on official siteUpdated Oct 30, 2025

Recommended Resource

Grant Writing Services on Fiverr

Top Pick

Struggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.